Systematic review with meta-analysis: Cytokines in fibromyalgia syndrome

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Üçeyler, Nurcan ^a   Häuser, Winfried ^b,c   Sommer, Claudia ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KLINIKUM SAARBRÜCKEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8;

BLOOD; FIBROMYALGIA; HUMAN; MEDICAL LITERATURE; METHODOLOGY; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; QUALITY CONTROL; REVIEW; SCORING SYSTEM; SKIN; SYSTEMATIC REVIEW;

EID: 80055005734     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-245     Document Type: Review

References (34)

1. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. Arthritis and rheumatism 1990 33 160 172 10.1002/art.1780330203 2306288 (Pubitemid 20098653)
2. [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]. Häuser W, Zimmer C, Felde E, Kollner V, Schmerz (Berlin, Germany) 2008 22 176 183
3. Prevalence of fibromyalgia: a survey in five European countries. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubere JP, et al. Semin Arthritis Rheum 2010 39 448 453 10.1016/j.semarthrit.2008.12.003 19250656
4. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, et al. Arthritis and rheumatism 2008 58 26 35 10.1002/art.23176 18163497
5. Cytokine regulation in animal models of neuropathic pain and in human diseases. çeyler N, Sommer C, Neurosci Lett 2008 437 194 198 10.1016/j.neulet.2008.03.050 18403115
6. Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Menzies V, Lyon DE, Biol Res Nurs 2010 11 387 394 10.1177/1099800409348328 19933683
7. Status of immune mediators in fibromyalgia. Gür A, Oktayolu P, Current pain and headache reports 2008 12 175 181 10.1007/s11916-008-0031-4 18796266
8. [Methodological fundamentals for the development of the guideline.]. Bernardy K, Klose P, çeyler N, Kopp I, Hauser W, Schmerz (Berlin, Germany) 2008
9. Review Manager (RevMan). Centre. TNC, 5.0 for Windows edn Copenhagen: The Cochrane Collaboration 2010
10. Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Amel Kashipaz MR, Swinden D, Todd I, Powell RJ, Clinical and experimental immunology 2003 132 360 365 10.1046/j.1365-2249.2003.02149.x 12699429 (Pubitemid 36560636)
11. Effects of balneotherapy on serum IL-1, PGE2 and LTB4 levels in fibromyalgia patients. Ardç F, zgen M, Aybek H, Rota S, ubukçu D, Gökgöz A, Rheumatology international 2007 27 441 446 10.1007/s00296-006-0237-x 17033835 (Pubitemid 46294983)
12. Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data. Barth H, Berg PA, Klein R, Advances in experimental medicine and biology 1999 467 487 496 10.1007/978-1-4615-4709-9-61 10721092 (Pubitemid 32202194)
13. Antipolymer antibody in Italian fibromyalgic patients. Bazzichi L, Giacomelli C, De Feo F, Giuliano T, Rossi A, Doveri M, Tani C, Wilson RB, Bombardieri S, Arthritis research & therapy 2007 9 86 10.1186/ar2285 22043277 (Pubitemid 47528097)
14. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, Ciapparelli A, Dell'Osso L, Bombardieri S, Clinical and experimental rheumatology 2007 25 225 230 17543146 (Pubitemid 46851426)
15. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Blanco I, Beritze N, Arguelles M, Carcaba V, Fernandez F, Janciauskiene S, Oikonomopoulou K, de Serres FJ, Fernandez-Bustillo E, Hollenberg MD, Clinical rheumatology 2010 29 1403 1412 10.1007/s10067-010-1474-7 20428906
16. Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFalpha), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia. Blanco I, Janciauskiene S, Nita I, Fernandez-Bustillo E, Carcaba V, Gallo C, Alvarez-Rico M, de Serres F, Beridze N, Clinical rheumatology 2010 29 189 197 10.1007/s10067-009-1318-5 19924498
17. Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. Feng J, Zhang Z, Li W, Shen X, Song W, Yang C, Chang F, Longmate J, Marek C, St Amand RP, et al. PloS one 2009 4 8480 10.1371/journal.pone.0008480 20041150
18. Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome. Hader N, Rimon D, Kinarty A, Lahat N, Arthritis and rheumatism 1991 34 866 872 10.1002/art.1780340712 1676263
19. Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index. Hernandez ME, Becerril E, Perez M, Leff P, Anton B, Estrada S, Estrada I, Sarasa M, Serrano E, Pavon L, BMC research notes 2010 3 156 10.1186/1756-0500-3-156 20525285
20. Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Iannuccelli C, Di Franco M, Alessandri C, Guzzo MP, Croia C, Di Sabato F, Foti M, Valesini G, Annals of the New York Academy of Sciences 2010 1193 78 83 10.1111/j.1749-6632.2009.05365.x 20398011
21. Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients. Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, Schelling G, Thiel M, Neuroimmunomodulation 2007 14 272 280 10.1159/000115041 18239379 (Pubitemid 351339994)
22. Adhesion molecules and cytokine expression in fibromyalgia patients: increased L-selectin on monocytes and neutrophils. Macedo JA, Hesse J, Turner JD, Ammerlaan W, Gierens A, Hellhammer DH, Muller CP, Journal of neuroimmunology 2007 188 159 166 10.1016/j.jneuroim.2007.06.002 17602758 (Pubitemid 47095025)
23. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Maes M, Libbrecht I, Van Hunsel F, Lin AH, De Clerck L, Stevens W, Kenis G, de Jongh R, Bosmans E, Neels H, Psychoneuroendocrinology 1999 24 371 383 10.1016/S0306-4530(98)00087-0 10341365 (Pubitemid 29204800)
24. Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Ortega E, Bote ME, Giraldo E, Garcia JJ, Scandinavian journal of medicine & science in sports 2010 20210910
25. Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia. Pay S, algüneri M, alkaner Z, Dinç A, Apras S, Ertenli I, Kiraz S, obankara V, Nagoya journal of medical science 2000 63 115 122 11201985
26. Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise. Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ, The open immunology journal 2010 3 9 18 20467575
27. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay S, Sprott H, The Journal of rheumatology 2003 30 146 150 12508404 (Pubitemid 36077786)
28. Evidence for an altered tryptophan metabolism in fibromyalgia. Schwarz MJ, Offenbaecher M, Neumeister A, Ewert T, Willeit M, Praschak-Rieder N, Zach J, Zacherl M, Lossau K, Weisser R, et al. Neurobiology of disease 2002 11 434 442 10.1006/nbdi.2002.0563 12586552 (Pubitemid 36269128)
29. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Togo F, Natelson BH, Adler GK, Ottenweller JE, Goldenberg DL, Struzik ZR, Yamamoto Y, Experimental biology and medicine (Maywood, NJ 2009 234 232 240 10.3181/0808-RM-254
30. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. çeyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C, Arthritis Rheum 2006 54 2656 2664 10.1002/art.22026 16871547 (Pubitemid 44205028)
31. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH, Rheumatology (Oxford, England) 2001 40 743 749 10.1093/rheumatology/40.7.743
32. Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months. Wang H, Moser M, Schiltenwolf M, Buchner M, The Journal of rheumatology 2008 35 1366 1370 18528959 (Pubitemid 352000786)
33. High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M, Amand RP, Shively JE, Experimental biology and medicine (Maywood, NJ) 2008 233 1171 1180 10.3181/0712-RM-328
34. Cytokines and depression in cases with fibromyalgia. Gür A, Karakoç M, Nas K, Remzi, evik, Denli A, Saraç J, The Journal of rheumatology 2002 29 358 361 11838856 (Pubitemid 34118788)